Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 AIDS and leishmaniasis.

Literature DB >> 9389941

AIDS and leishmaniasis.

R N Davidson.

Abstract

Entities: Disease

Mesh：

Substances：
Antiprotozoal Agents

Year: 1997 PMID： 9389941 PMCID： PMC1195849 DOI： 10.1136/sti.73.4.237

Source DB: PubMed Journal: Genitourin Med ISSN： 0266-4348

× No keyword cloud information.

14 in total

1. Interferon-gamma associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS.

Authors: O Lortholary; D Mechali; D Christiaens; M Gougerot Pocidalo; M Brandely; P Babinet
Journal: Rev Infect Dis Date: 1990 Mar-Apr

2. Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome).

Authors: R Russo; L C Nigro; S Minniti; A Montineri; L Gradoni; L Caldeira; R N Davidson
Journal: J Infect Date: 1996-03 Impact factor: 6.072

3. [Fever of unknown origin in patients infected with the human immunodeficiency virus].

Authors: C Carbonell Biot; J Ena Muñoz; F Pasquau Liaño; P Badía Ferrando; A Ortiz de Salazar Martín; A Vilar Zanón
Journal: Rev Clin Esp Date: 1996-01 Impact factor: 1.556

4. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.

Authors: E Ribera; I Ocaña; J de Otero; E Cortes; I Gasser; A Pahissa
Journal: Am J Med Date: 1996-05 Impact factor: 4.965

5. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma.

Authors: M de Górgolas; J M Castrillo; M L Fernández Guerrero
Journal: Clin Infect Dis Date: 1993-07 Impact factor: 9.079

6. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial.

Authors: R N Davidson; L Di Martino; L Gradoni; R Giacchino; R Russo; G B Gaeta; R Pempinello; S Scott; F Raimondi; A Cascio
Journal: Q J Med Date: 1994-02

Review 7. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.

Authors: J Torre-Cisneros; J L Villanueva; J M Kindelan; R Jurado; P Sanchez-Guijo
Journal: Clin Infect Dis Date: 1993-10 Impact factor: 9.079

Review 3. [Cutaneous leishmaniasis].

Authors: C D Enk; K Gardlo; M Hochberg; A Ingber; T Ruzicka
Journal: Hautarzt Date: 2003-04-18 Impact factor: 0.751

3 in total

AIDS and leishmaniasis.

1. Interferon-gamma associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS.

2. Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome).

3. [Fever of unknown origin in patients infected with the human immunodeficiency virus].

4. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.

5. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma.

6. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial.

Review 7. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.

8. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?

9. Fever of uncertain origin in patients infected with the human immunodeficiency virus.

10. Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice.

Review 1. Amphotericin B lipid complex: in visceral leishmaniasis.

Review 2. Practical guide for the treatment of leishmaniasis.

Review 3. [Cutaneous leishmaniasis].